
Neurologist

No OPD information available
Ataxia-Telangiectasia
Telangiectasia
Apraxia
C Syndrome
Drug Induced Dyskinesia
Oculomotor Apraxia Cogan Type
Spinocerebellar Ataxia Type 4
Spinocerebellar Ataxia Type 5
Acromicric Dysplasia
Acute Cerebellar Ataxia
Acute Interstitial Pneumonia
Aicardi-Goutieres Syndrome
Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
Astrocytoma
Crouzon Syndrome
Glioblastoma
Glioma
Gliomatosis Cerebri
Hereditary Ataxia
Infertility
Interstitial Lung Disease
Olivopontocerebellar Atrophy
Phocomelia
Pneumonia
Primary Lateral Sclerosis
Prostate Cancer
Prostatectomy
Pulmonary Fibrosis
Roberts Syndrome
Silicosis
Sirenomelia
Spinocerebellar Ataxia
Strep Throat
West Nile Virus Infection
Martin F. Lavin is a male healthcare provider who helps people with various health conditions like Ataxia-Telangiectasia, ALS, and prostate cancer. He also treats diseases like pneumonia, glioblastoma, and infertility. Martin F. Lavin uses special skills and treatments to care for his patients.
Martin F. Lavin talks to patients in a friendly and clear way, which helps them feel comfortable and trust him. Patients rely on him because he listens carefully to their concerns and explains things well.
To stay up-to-date with the latest medical knowledge, Martin F. Lavin reads research articles and attends conferences. This helps him provide the best care for his patients. He also works closely with other medical professionals to share ideas and learn from each other.
Martin F. Lavin's work has had a positive impact on many patients' lives. For example, his research on Ataxia Telangiectasia revealed important insights into mitochondrial dysfunction and oxidative stress. He has also conducted clinical trials to test new treatments for conditions like Ataxia-telangiectasia.
One of Martin F. Lavin's notable publications is "Ataxia Telangiectasia patient-derived neuronal and brain organoid models reveal mitochondrial dysfunction and oxidative stress." This study was published in Neurobiology of disease in April 2024. He has also conducted a clinical trial testing the ability of Triheptanoin to protect airway cells against glucose deprivation in Ataxia-telangiectasia patients.
Overall, Martin F. Lavin is a dedicated healthcare provider who uses his skills and knowledge to help patients with various health conditions. His commitment to staying updated with the latest research and collaborating with colleagues shows his dedication to providing excellent care.
Enrollment Status: Completed
Published: July 20, 2023
Intervention Type: Dietary supplement
Study Drug:
Study Phase: Phase 2
